Trials / Recruiting
RecruitingNCT06345976
Functional Impairment in Albinism
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including : * In the integumentary region: fair skin tone, with white hair, eyelashes and eyebrows. * Ophthalmological: reduced visual acuity, photophobia, nystagmus, transilluminated blue irises, hypopigmentation of the retina at the back of the eye with fovea plana. As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire | On-line self-questionnaire, in the form of an 18-question form, the link to which is sent by e-mail to patients with albinism who have agreed to take part in the study. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
- First posted
- 2024-04-03
- Last updated
- 2025-02-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06345976. Inclusion in this directory is not an endorsement.